vs
Side-by-side financial comparison of Element Solutions Inc (ESI) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Element Solutions Inc is the larger business by last-quarter revenue ($840.0M vs $493.8M, roughly 1.7× Pediatrix Medical Group, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 6.7%, a 0.2% gap on every dollar of revenue. On growth, Element Solutions Inc posted the faster year-over-year revenue change (41.0% vs -1.7%). Over the past eight quarters, Element Solutions Inc's revenue compounded faster (17.1% CAGR vs -0.1%).
Element Solutions Inc is an American specialty chemicals production corporation listed on the New York Stock Exchange.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
ESI vs MD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $840.0M | $493.8M |
| Net Profit | $56.0M | $33.7M |
| Gross Margin | 38.4% | — |
| Operating Margin | 13.3% | 9.9% |
| Net Margin | 6.7% | 6.8% |
| Revenue YoY | 41.0% | -1.7% |
| Net Profit YoY | -43.0% | 10.5% |
| EPS (diluted) | $0.23 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $840.0M | — | ||
| Q4 25 | $676.2M | $493.8M | ||
| Q3 25 | $656.1M | $492.9M | ||
| Q2 25 | $625.2M | $468.8M | ||
| Q1 25 | $593.7M | $458.4M | ||
| Q4 24 | $624.2M | $502.4M | ||
| Q3 24 | $645.0M | $511.2M | ||
| Q2 24 | $612.7M | $504.3M |
| Q1 26 | $56.0M | — | ||
| Q4 25 | $6.2M | $33.7M | ||
| Q3 25 | $39.3M | $71.7M | ||
| Q2 25 | $47.4M | $39.3M | ||
| Q1 25 | $98.0M | $20.7M | ||
| Q4 24 | $54.7M | $30.5M | ||
| Q3 24 | $40.3M | $19.4M | ||
| Q2 24 | $93.2M | $-153.0M |
| Q1 26 | 38.4% | — | ||
| Q4 25 | 40.9% | — | ||
| Q3 25 | 42.2% | — | ||
| Q2 25 | 42.6% | — | ||
| Q1 25 | 42.2% | — | ||
| Q4 24 | 41.0% | — | ||
| Q3 24 | 41.5% | — | ||
| Q2 24 | 43.6% | — |
| Q1 26 | 13.3% | — | ||
| Q4 25 | 10.3% | 9.9% | ||
| Q3 25 | 15.4% | 13.8% | ||
| Q2 25 | 15.1% | 12.8% | ||
| Q1 25 | 13.0% | 7.0% | ||
| Q4 24 | 12.0% | 7.8% | ||
| Q3 24 | 14.7% | 6.6% | ||
| Q2 24 | 15.7% | -31.3% |
| Q1 26 | 6.7% | — | ||
| Q4 25 | 0.9% | 6.8% | ||
| Q3 25 | 6.0% | 14.5% | ||
| Q2 25 | 7.6% | 8.4% | ||
| Q1 25 | 16.5% | 4.5% | ||
| Q4 24 | 8.8% | 6.1% | ||
| Q3 24 | 6.2% | 3.8% | ||
| Q2 24 | 15.2% | -30.3% |
| Q1 26 | $0.23 | — | ||
| Q4 25 | $0.03 | $0.40 | ||
| Q3 25 | $0.16 | $0.84 | ||
| Q2 25 | $0.20 | $0.46 | ||
| Q1 25 | $0.40 | $0.24 | ||
| Q4 24 | $0.22 | $0.37 | ||
| Q3 24 | $0.17 | $0.23 | ||
| Q2 24 | $0.39 | $-1.84 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.3M | $375.2M |
| Total DebtLower is stronger | — | $570.5M |
| Stockholders' EquityBook value | $2.7B | $865.9M |
| Total Assets | $5.7B | $2.2B |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $177.3M | — | ||
| Q4 25 | $626.5M | $375.2M | ||
| Q3 25 | $594.3M | $340.1M | ||
| Q2 25 | $529.9M | $224.7M | ||
| Q1 25 | $499.2M | $99.0M | ||
| Q4 24 | $359.4M | $229.9M | ||
| Q3 24 | $376.0M | $103.8M | ||
| Q2 24 | $309.3M | $19.4M |
| Q1 26 | — | — | ||
| Q4 25 | $1.6B | $570.5M | ||
| Q3 25 | $1.6B | $577.2M | ||
| Q2 25 | $1.6B | $583.9M | ||
| Q1 25 | $1.6B | $590.5M | ||
| Q4 24 | $1.8B | $597.1M | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.9B | — |
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $865.9M | ||
| Q3 25 | $2.7B | $890.7M | ||
| Q2 25 | $2.6B | $833.8M | ||
| Q1 25 | $2.5B | $789.2M | ||
| Q4 24 | $2.4B | $764.9M | ||
| Q3 24 | $2.4B | $732.5M | ||
| Q2 24 | $2.4B | $706.5M |
| Q1 26 | $5.7B | — | ||
| Q4 25 | $5.1B | $2.2B | ||
| Q3 25 | $5.0B | $2.2B | ||
| Q2 25 | $5.0B | $2.1B | ||
| Q1 25 | $4.8B | $2.0B | ||
| Q4 24 | $4.9B | $2.2B | ||
| Q3 24 | $5.1B | $2.1B | ||
| Q2 24 | $5.0B | $2.0B |
| Q1 26 | — | — | ||
| Q4 25 | 0.61× | 0.66× | ||
| Q3 25 | 0.61× | 0.65× | ||
| Q2 25 | 0.62× | 0.70× | ||
| Q1 25 | 0.64× | 0.75× | ||
| Q4 24 | 0.76× | 0.78× | ||
| Q3 24 | 0.78× | — | ||
| Q2 24 | 0.81× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $114.1M |
| Free Cash FlowOCF − Capex | $-74.2M | — |
| FCF MarginFCF / Revenue | -8.8% | — |
| Capex IntensityCapex / Revenue | 3.0% | — |
| Cash ConversionOCF / Net Profit | — | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $114.1M | ||
| Q3 25 | $100.1M | $137.3M | ||
| Q2 25 | — | $137.2M | ||
| Q1 25 | $26.0M | $-117.5M | ||
| Q4 24 | — | $133.0M | ||
| Q3 24 | $98.5M | $91.8M | ||
| Q2 24 | — | $107.0M |
| Q1 26 | $-74.2M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $83.6M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $15.0M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $85.9M | — | ||
| Q2 24 | — | — |
| Q1 26 | -8.8% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 12.7% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 2.5% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 13.3% | — | ||
| Q2 24 | — | — |
| Q1 26 | 3.0% | — | ||
| Q4 25 | 2.5% | — | ||
| Q3 25 | 2.5% | — | ||
| Q2 25 | 2.8% | — | ||
| Q1 25 | 1.9% | — | ||
| Q4 24 | 3.6% | — | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 2.4% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 3.39× | ||
| Q3 25 | 2.55× | 1.91× | ||
| Q2 25 | — | 3.49× | ||
| Q1 25 | 0.27× | -5.66× | ||
| Q4 24 | — | 4.36× | ||
| Q3 24 | 2.44× | 4.72× | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESI
| Electronics ex-Metals | $377.8M | 45% |
| Pass-through Metals | $255.7M | 30% |
| Other | $206.5M | 25% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
